Ionis Pharmaceuticals
Utility Patent Applications
Last updated:
List of all Ionis Pharmaceuticals patents 146 in total
Status | Patent |
---|---|
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION Filling date: 8 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: MODULATORS OF HSD17B13 EXPRESSION Filling date: 8 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: SYNTHESIS OF OLIGOMERIC COMPOUNDS COMPRISING PHOSPHOROTHIOATE DIESTER AND PHOSPHODIESTER LINKAGES Filling date: 8 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: MODULATORS OF MALAT1 EXPRESSION Filling date: 8 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: MODULATORS OF IRF4 EXPRESSION Filling date: 8 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING TAU EXPRESSION Filling date: 8 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: MODULATORS OF COMPLEMENT FACTOR B Filling date: 8 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: COMPOUNDS AND METHODS FOR REDUCING FUS EXPRESSION Filling date: 8 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: Compositions and Methods for Modulating MECP2 Expression Filling date: 8 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS Filling date: 8 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: COMPOUNDS AND METHODS FOR REDUCING ATXN3 EXPRESSION Filling date: 8 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS Filling date: 8 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: MODULATION OF PREKALLIKREIN (PKK) EXPRESSION Filling date: 8 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: COMPOSITIONS COMPRISING ALTERNATING 2'-MODIFIED NUCLEOSIDES FOR USE IN GENE MODULATION Filling date: 8 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: METHODS FOR REDUCING ATAXIN-2 EXPRESSION Filling date: 8 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: COMPOUNDS AND METHODS FOR MODULATING ANGIOTENSINOGEN EXPRESSION Filling date: 8 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: METHODS OF TREATING BREAST CANCER Filling date: 8 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: COMPOUNDS AND METHODS FOR REDUCING PMP22 EXPRESSION Filling date: 8 Sep 2025 Issue date: 14 Apr 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING AMYOTROPHIC LATERAL SCLEROSIS Filling date: 8 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: Compounds and Methods for Reducing ATXN2 Expression Filling date: 8 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: COMPOUNDS AND METHODS FOR MODULATING SMN2 Filling date: 8 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: MODULATORS OF IRF5 EXPRESSION Filling date: 8 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION Filling date: 8 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: CHIRALLY ENRICHED OLIGOMERIC COMPOUNDS Filling date: 8 Sep 2025 Issue date: 9 Dec 2021 |
Application | Utility: OLIGONUCLEOTIDE MEDIATED NO-GO DECAY Filling date: 8 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: COMPOUNDS AND METHODS FOR REDUCING FXI EXPRESSION Filling date: 8 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: ALLELE SPECIFIC MODULATORS OF P23H RHODOPSIN Filling date: 8 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: GLP-1 Receptor Ligand Moiety Conjugated Oligonucleotides and Uses Thereof Filling date: 8 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: METHODS FOR REDUCING LRRK2 EXPRESSION Filling date: 8 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: Compounds and Methods for Modulation of Transcript Processing Filling date: 8 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: Compounds and Methods for the Modulation of Proteins Filling date: 8 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: Selective Antisense Compounds and Uses Thereof Filling date: 8 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: COMPOSITIONS FOR MODULATING EXPRESSION OF C9ORF72 ANTISENSE TRANSCRIPT Filling date: 8 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING GROWTH HORMONE RECEPTOR EXPRESSION Filling date: 8 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: MODULATORS OF ENaC EXPRESSION Filling date: 8 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: MODULATION OF FACTOR 11 EXPRESSION Filling date: 8 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: Conjugated Antisense Compounds for Use in Therapy Filling date: 8 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: METHODS FOR REDUCING C9ORF72 EXPRESSION Filling date: 8 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: METHODS OF MODULATING ANTISENSE ACTIVITY Filling date: 8 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: MODULATORS OF EZH2 EXPRESSION Filling date: 8 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: Selective Antisense Compounds and Uses Thereof Filling date: 8 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: Oligomeric Compounds Comprising Bicyclic Nucleotides and Uses Thereof Filling date: 8 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: COMPOUNDS AND METHODS FOR REDUCING SPDEF EXPRESSION Filling date: 8 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: MODULATION OF HUNTINGTIN EXPRESSION Filling date: 8 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: COMPOSITIONS AND METHODS Filling date: 8 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: METHODS OF MODULATING ANTISENSE ACTIVITY Filling date: 8 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: MODULATORS OF YAP1 EXPRESSION Filling date: 8 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: MODULATION OF TRANSTHYRETIN EXPRESSION Filling date: 8 Sep 2025 Issue date: 1 Apr 2021 |
Showing 1 to 50 of 146 patents.